Search results for "respiratory syncytial virus"

showing 10 items of 36 documents

Temporal association between the influenza virus and respiratory syncytial virus (RSV): RSV as a predictor of seasonal influenza.

2016

SUMMARYEpidemiologists agree that there is a prevailing seasonality in the presentation of epidemic waves of respiratory syncytial virus (RSV) infections and influenza. The aim of this study is to quantify the potential relationship between the activity of RSV, with respect to the influenza virus, in order to use the RSV seasonal curve as a predictor of the evolution of an influenza virus epidemic wave. Two statistical tools, logistic regression and time series, are used for predicting the evolution of influenza. Both logistic models and time series of influenza consider RSV information from previous weeks. Data consist of influenza and confirmed RSV cases reported in Comunitat Valenciana (…

0301 basic medicineAdultMaleTime FactorsMultinomial logistic modelAdolescentEpidemiologyBinomial regression030106 microbiologyRespiratory Syncytial Virus InfectionsBiologyLogistic regressionmedicine.disease_causeVirusSeasonal influenza03 medical and health sciencesYoung AdultInfluenza HumanmedicineHumansChildEpidemicsAgedAged 80 and overInfant Newbornvirus diseasesInfantMiddle AgedOrthomyxoviridaeVirologyOriginal PapersInfectious DiseasesRespiratory syncytial virus (RSV)Logistic ModelsSpainChild PreschoolRespiratory Syncytial Virus HumanFemaleSeasonsEpidemiology and infection
researchProduct

Comparison of the BD Directigen Flu A+B Kit and the Abbott TestPack RSV with a multiplex RT-PCR ELISA for rapid detection of influenza viruses and re…

2005

ABSTRACTThe Directigen Flu A+B enzyme immunoassay and the Abbott TestPack RSV enzyme immunoassay were each compared with a multiplex RT-PCR ELISA by testing 635 nasopharyngeal aspirates collected from children aged < 16 years who had been hospitalised with acute respiratory tract infection during the epidemic season 2002–2003. In this study, the sensitivity of the Directigen Flu A+B assay was unacceptably low (29.3% and 10.0%, respectively) for the detection of influenza A and B viruses. The sensitivity of the Abbott TestPack RSV assay (77.4%) was acceptable and in agreement with the multiplex RT-PCR ELISA.

Microbiology (medical)Paramyxoviridaerespiratory syncytial virusrespiratory tract infectionEnzyme-Linked Immunosorbent AssayPolymerase Chain ReactionSensitivity and Specificityinfluenza virusVirusAssaysMicrobiologyPneumovirinaeNasopharynxMultiplex polymerase chain reactionmedicineMultiplexProspective StudiesMononegaviralesbiologymedicine.diagnostic_testReverse Transcriptase Polymerase Chain Reactionvirus diseasesGeneral Medicinebiology.organism_classificationenzyme immunoassayVirologyInfluenza B virusInfectious Diseasesmultiplex RT-PCRInfluenza A virusRespiratory Syncytial Virus HumanImmunoassayReagent Kits DiagnosticViral diseaseClinical Microbiology and Infection
researchProduct

Nosocomial infection: A risk factor for a complicated course in children with respiratory syncytial virus infection – Results from a prospective mult…

2008

BACKGROUND: Nosocomially acquired respiratory syncytial virus infections (RSV-NI) may cause serious problems in hospitalized paediatric patients. Hitherto, prospectively collected representative data on RSV-NI from multicenter studies in Germany are limited. METHODS: The DMS RSV Ped database was designed for the prospective multicenter documentation and analysis of clinically relevant aspects of the management of inpatients with RSV-infection. The study covered six consecutive seasons (1999-2005); the surveillance took place in 14 paediatric hospitals in Germany. RESULTS: Of the 1568 prospectively documented RSV-infections, 6% (n=90) were NI and 94% (n=1478) were community acquired (CA). A …

MalePediatricsmedicine.medical_specialtyDatabases FactualHeart diseasemedicine.medical_treatmentRespiratory Syncytial Virus InfectionsSeverity of Illness IndexRisk FactorsGermanyNasopharynxSeverity of illnessmedicineHumansProspective StudiesRisk factorProspective cohort studyMechanical ventilationCross Infectionbusiness.industryRespiratory diseaseInfant NewbornPublic Health Environmental and Occupational HealthInfantHospitals Pediatricmedicine.diseaseRespiratory Syncytial VirusesCommunity-Acquired InfectionsPopulation SurveillanceRegression AnalysisFemaleViral diseaseComplicationbusinessInfant PrematureInternational Journal of Hygiene and Environmental Health
researchProduct

Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis.

2020

Abstract Background Throughout the 5000-year history of China, more than 300 epidemics were recorded. Traditional Chinese herbal medicine (TCM) has been used effectively to combat each of these epidemics’ infections, and saved many lives. To date, there are hundreds of herbal TCM formulae developed for the purpose of prevention and treatment during epidemic infections. When COVID-19 ravaged the Wuhan district in China in early January 2020, without a deep understanding about the nature of COVID-19, patients admitted to the TCM Hospital in Wuhan were immediately treated with TCM and reported later with >90% efficacy. Approach We conducted conduct a systematic survey of various TCM herbal pre…

PTGS2 Prostaglandin-endoperoxide synthase 2BattleAIV avian influenza virusCoV coronavirusPharmaceutical ScienceiNOS nitric oxide synthaseViral infection0302 clinical medicinePA patchouli alcoholSARS Severe Acute Respiratory SyndromeSMD Sheganmahuang decoctionDrug DiscoveryPandemicIL InterleukinMedicine Chinese TraditionalALI acute lung injuriesmedia_commonCOVID-19 coronavirus disease 2019MXSG Ma xing shi gan decoction0303 health sciencesTNF tumor necrosis factorClinical Trials as TopicCCL2 CC chemokine ligand 2FM1 FM1 coronavirusICU intensive care unitc-AMP cyclic adenosine phosphateHIV human immunodeficiency virus030220 oncology & carcinogenesisCOX-2 cyclooxygenase-2Molecular MedicineHerbal preparationsMedicinal herbsAbbreviations: ACE2 angiotensin-converting enzyme IITCM traditional Chinese medicineHSV-1 herpes simplex virus 1CASP3 caspase 3medicine.medical_specialtyChinaCoronavirus disease 2019 (COVID-19)Systematic surveymedia_common.quotation_subjectJEV Japanese encephalitis virusNF-κB nuclear factor kappa B cellsAntiviral AgentsArticleWHO World Health Organization03 medical and health sciencesIEC-6 rat intestinal epithelial cell line 6SOD superoxide dismutaseCDC Center for Disease Control and PreventionmedicineAVP arginine vasopressinPGE2 prostaglandin E2HumansIntensive care medicineLH Lianhuaqingwen capsule030304 developmental biologyPharmacologyMedicinal herbMDA malondialdehydeGCGJ Gancao ganjiang decoctionNO nitric oxidePlants Medicinalbusiness.industrySARS-CoV-2COVID-19CXCL C-X-C- motif chemokineMDCK Madin-Darby Canine Kidney cellsTLR-4 Toll-like receptor-4COVID-19 Drug TreatmentComplementary and alternative medicineViral infectionLPS lipopolysaccharidesRSV respiratory syncytial virusQFPD Qingfeipaidu decoctionbusinessLung congestionECMO extracorporeal membrane oxygenationMAPK mitogen-activated protein kinasePhytotherapyDrugs Chinese HerbalPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

Pediatric intensive care admissions for respiratory syncytial virus bronchiolitis in France: results of e retrospective survey and evaluation of the …

2012

International audience

PediatricMedical informationRespiratory syncytial virus bronchiolitis[ SHS.ECO ] Humanities and Social Sciences/Economies and financesFrance[SHS.ECO] Humanities and Social Sciences/Economics and Finance[SHS.ECO]Humanities and Social Sciences/Economics and FinanceComputingMilieux_MISCELLANEOUS
researchProduct

Bronchiolitis: The New American Academy of Pediatrics Guidelines

2008

Respiratory Syncytial Virus (RSV) is the leading cause of hospitalization for lower respiratory tract infections (LRTI) in young children worldwide. RSV is an important cause of LRTI in infants and a variety of factors, such as gender, age at admission, gestational age, birth weight, and exposure to tobacco smoke and breast feeding may affect the prevalence of RSV-related disease and, possibly, the risk of developing asthma-like symptoms during the school years. AAP in 2006 formulated the new guidelines on diagnosis and management of bronchiolitis, giving recommendations on different conditions requesting clinical decisions also in terms of prevention.

PalivizumabPediatricsmedicine.medical_specialtyBirth weightRespiratory Syncytial Virus InfectionsDiseaseAntibodies Monoclonal HumanizedAntiviral AgentsTobacco smokeRisk FactorsPrevalencemedicineBronchiolitis ViralHumansPharmacology (medical)PalivizumabPharmacologyEvidence-Based MedicineRespiratory tract infectionsbusiness.industryAntibodies MonoclonalGestational agemedicine.diseaserespiratory tract diseasesInfectious DiseasesOncologyBronchiolitisPractice Guidelines as TopicBronchiolitisbusinessBreast feedingmedicine.drugJournal of Chemotherapy
researchProduct

Children, parents and Respiratory Syncytial Virus in Palermo, Italy: prevention is primary.

2010

A study was conducted to describe the characteristics of the Respiratory Syncytial Virus (RSV) infection cases occurring in the season 2006—7 in Palermo, Italy, and to evaluate the parents’ knowledge and behaviours concerning prevention and control of acute respiratory infections (ARIs). All children aged between 0 and 2 years, admitted for a lower respiratory tract infection (LRTI) between October 2006 and May 2007, were enrolled in the study. Data were collected about demographic and household characteristics. Furthermore, their parents were asked to compile a structured questionnaire on transmission, prevention and management of ARIs in children. A total of 198 children with a diagnosis…

AdultMaleParentsHealth Knowledge Attitudes Practicemedicine.medical_specialtyPediatricsSettore MED/17 - Malattie InfettiveAdolescentmedia_common.quotation_subjectEthnic groupRespiratory Syncytial Virus InfectionsSettore MED/42 - Igiene Generale E ApplicataPediatricschildhood illness epidemiology infection controlYoung AdultHygieneSurveys and QuestionnairesLower respiratory tract infectionEpidemiologyEthnicitymedicineHumansInfection controlYoung adultRespiratory Tract Infectionsmedia_commonRespiratory tract infectionsTransmission (medicine)business.industryAge FactorsInfantmedicine.diseaseRespiratory Syncytial Virusesrespiratory tract diseasesPrimary PreventionItalyPediatrics Perinatology and Child HealthEducational StatusFemalebusiness
researchProduct

Chaperoning the Mononegavirales: Current Knowledge and Future Directions

2018

This article belongs to the Special Issue Breakthroughs in Viral Replication.

0301 basic medicineProtein Foldingrespiratory syncytial viruslcsh:QR1-502ReviewRespiratory syncytial virusVirus Replicationmedicine.disease_causelcsh:MicrobiologyHsp70Ebola virusantiviralsChaperonesMononegaviralesOrder MononegaviralesbiologyAntivirals<i>Mononegavirales</i>Hsp90Respiratory Syncytial VirusesInfectious DiseasesMumps virusHost-Pathogen InteractionsProtein foldingHsp90biology_otherComputational biologyAntiviral Agents03 medical and health sciencesEmerging infectionsVirologymedicineHumanschaperonesHSP70 Heat-Shock Proteinsrabies virusHSP90 Heat-Shock ProteinsEbola virusObligatebiology.organism_classificationCCT030104 developmental biologyMeasles virusRabies virusChaperone (protein)measles virusbiology.proteinmumps virusMononegaviralesMolecular ChaperonesViruses
researchProduct

Epidemiological assessment of Respiratory Syncytial Virus infection in hospitalized infants, during the season 2005–2006 in Palermo, Italy

2009

Abstract Objectives Respiratory Syncytial Virus (RSV) is the leading cause of hospitalization for lower respiratory tract infections (LRTI) in young children worldwide. We evaluate the epidemiological and clinical patterns of RSV infection in infants hospitalized for LRTI in in Palermo, South Italy, Sicily. Methods We collected the demographic details of infants hospitalized to G. Di Cristina Children's Hospital in Palermo for LRTI between November 2005 and May 2006. We also included all cases occurred in newborns hospitalized in the Neonatal Intensive Care Unit (NICU) Of Palermo. Results During the studied period, 335/705 hospitalized infants for LRTI were enrolled in the study. The trend …

Pediatricsmedicine.medical_specialtyNeonatal intensive care unitSettore MED/17 - Malattie InfettiveRespiratory tract infectionsMaternal and child healthbusiness.industryvirusesResearchlcsh:RJ1-570Infantlcsh:Pediatricsmedicine.diseaseVirusrespiratory tract diseasesHospitalizationLower Respiratory Tract InfectionLower respiratory tract infectionEpidemiologymedicineRespiratory Syncytial VirusRespiratory systembusinessItalian Journal of Pediatrics
researchProduct

RSV disease in infants and young children: Can we see a brighter future?

2022

Respiratory syncytial virus (RSV) is a highly contagious seasonal virus and the leading cause of Lower Respiratory Tract Infections (LRTI), including pneumonia and bronchiolitis in children. RSV-related LRTI cause approximately 3 million hospitalizations and 120,000 deaths annually among children &lt;5 years of age. The majority of the burden of RSV occurs in previously healthy infants. Only a monoclonal antibody (mAb) has been approved against RSV infections in a restricted group, leaving an urgent unmet need for a large number of children potentially benefiting from preventive measures. Approaches under development include maternal vaccines to protect newborns, extended half-life monoclon…

respiratory syncytial virusImmunologyRSV vaccinesRespiratory Syncytial Virus InfectionsCommunicable DiseasesRSV preventionRSV all infantsImmunology and AllergyHumansChildmonoclonal antibodieRespiratory Tract InfectionsPharmacologyRSV all infantInfant NewbornRSVInfantAntibodies MonoclonalRSV paediatric burdenHospitalizationLRTIRSV epidemiologyChild PreschoolRespiratory Syncytial Virus HumanBronchiolitismonoclonal antibodiesLRTI; RSV; RSV all infants; RSV epidemiology; RSV paediatric burden; RSV prevention; RSV vaccines; monoclonal antibodies; respiratory syncytial virusRSV prevention: RSV vaccines.Human vaccinesimmunotherapeutics
researchProduct